United States Proton Therapy Market has potential to surpass US$ 16 Billion by the end of 2024. The research and development of proton therapy has been happening since last four decade and technology has been commercially in operation since last three decades. In current outlook manufacturer developed compact cyclotron, advanced delivery systems. Proton therapy is advance and effective therapy that perform better results over conventional therapy.

Global infectious disease diagnostics market is anticipated to achieve USD 19.35 billion by 2022, at a CAGR of 5.6%. The study tracks and analyzes competitive developments like product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies within the communicable disease medical specialty market.

Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The report studies the Point of Care Diagnostics market by Prescription-based Testing and OTC-based Testing.

For cancer care immunotherapy has come out as the newest frontier in India.

It utilizes the body’s natural healing power to facilitate the immune system to fight diseases like cancer.

In the last few decades, it has been observed that immunotherapy has become a key part of treatment for many diseases. But all immunotherapies work in a different manner.

Some of them boost the immune system while others aim to attack very specific cell types that they target specific cells which are found in tumors.This is what is known as targeted cell treatment where it attacks only cancerous cells.

Immunotherapy is unlike conventional treatments of chemotherapy and radiation therapy where the treatment effects on normal cells as well.

Global Contact Lens Market will cross USD 13 Billion by 2024. A new report compiled by Renub Research titled “Contact Lens Market, Global Forecast by Segments (Corrective Lens, Cosmetic & Lifestyle oriented Lens, Others) Materials (Silicone hydrogel Soft Contact Lens, Methacrylate hydrogel Soft Contact Lens, Gas-Permeable Contact Lens, Others) Design (Multifocal, Spherical, Toric, Others ) Region (North America, Europe, Asia-Pacifics, Rest of the World) Companies (Alcon Laboratories, Inc., Valeant Pharmaceutical International Inc., Cooper Vision and Johnson & Johnson Services, Inc.)” studies the Global Contact Lens.